Literature DB >> 33353549

May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)?

Raffaele Scarpa1, Francesco Caso2, Luisa Costa2, Saverio Passavanti2, Maria Grazia Vitale3, Claudia Trojaniello3, Antonio Del Puente2, Paolo A Ascierto3.   

Abstract

BACKGROUND: In 1918 an unknown infectious agent spread around the world infecting over one-third of the general population and killing almost 50 million people. Many countries were at war, the First World War. Since Spain was a neutral country and Spanish press could report about the infection without censorship, this condition is commonly remembered as "Spanish influenza". This review examines several aspects during the 1918 influenza pandemic to bring out evidences which might be useful to imagine the possible magnitude of the present coronavirus disease 2019 (COVID-19).
METHODS: In the first part of this review we will examine the origin of the SARS-Coronavirus-2 and 1918 Spanish Influenza Virus and the role played by host and environment in its diffusion. We will also include in our analysis an evaluation of different approaches utilized to restrain the spread of pandemic and to treat infected patients. In the second part, we will try to imagine the magnitude of the present COVID-19 pandemic and the possible measures able to restrain in the present environment its spread.
RESULTS: Several factors characterize the outcome in a viral pandemic infection. They include the complete knowledge of the virus, the complete knowledge of the host and of the environment where the host lives and the pandemic develops.
CONCLUSION: By comparing the situation seen in 1918 with the current one, we are now in a more favourable position. The experience of the past teaches us that their success is linked to a rapid, constant and lasting application. Then, rather than coercion, awareness of the need to observe such prevention measures works better.

Entities:  

Keywords:  Antiviral therapy; Biologics; COVID-19; Immune response; JAK-inhibitors; Monoclonal antibodies; Passive antibody administration; SARS-CoV-2; Spanish influenza; Vaccines

Year:  2020        PMID: 33353549      PMCID: PMC7753514          DOI: 10.1186/s12967-020-02673-6

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


  102 in total

1.  Observations on mortality during the 1918 influenza pandemic.

Authors:  J Luk; P Gross; W W Thompson
Journal:  Clin Infect Dis       Date:  2001-09-17       Impact factor: 9.079

2.  Characterization of the 1918 influenza virus polymerase genes.

Authors:  Jeffery K Taubenberger; Ann H Reid; Raina M Lourens; Ruixue Wang; Guozhong Jin; Thomas G Fanning
Journal:  Nature       Date:  2005-10-06       Impact factor: 49.962

3.  Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities.

Authors:  James Stevens; Ola Blixt; Laurel Glaser; Jeffery K Taubenberger; Peter Palese; James C Paulson; Ian A Wilson
Journal:  J Mol Biol       Date:  2005-11-18       Impact factor: 5.469

4.  Initial genetic characterization of the 1918 "Spanish" influenza virus.

Authors:  J K Taubenberger; A H Reid; A E Krafft; K E Bijwaard; T G Fanning
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

5.  Dating the emergence of pandemic influenza viruses.

Authors:  Gavin J D Smith; Justin Bahl; Dhanasekaran Vijaykrishna; Jinxia Zhang; Leo L M Poon; Honglin Chen; Robert G Webster; J S Malik Peiris; Yi Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-13       Impact factor: 11.205

6.  Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene.

Authors:  A H Reid; T G Fanning; J V Hultin; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity.

Authors:  Laurel Glaser; James Stevens; Dmitriy Zamarin; Ian A Wilson; Adolfo García-Sastre; Terrence M Tumpey; Christopher F Basler; Jeffery K Taubenberger; Peter Palese
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  The site of origin of the 1918 influenza pandemic and its public health implications.

Authors:  John M Barry
Journal:  J Transl Med       Date:  2004-01-20       Impact factor: 5.531

Review 9.  Back to the Future: Lessons Learned From the 1918 Influenza Pandemic.

Authors:  Kirsty R Short; Katherine Kedzierska; Carolien E van de Sandt
Journal:  Front Cell Infect Microbiol       Date:  2018-10-08       Impact factor: 5.293

Review 10.  Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic.

Authors:  Rafi Ahmed; Michael B A Oldstone; Peter Palese
Journal:  Nat Immunol       Date:  2007-11       Impact factor: 25.606

View more
  4 in total

1.  Effect Evaluation of Echocardiography on Right Ventricular Function in Patients after the Recovering from Coronavirus Disease 2019.

Authors:  Jianqing Yang; Ping Liu; Mang Zhong; Ting Luo; Guolong Lei; Chunfeng Liao
Journal:  Comput Math Methods Med       Date:  2022-07-14       Impact factor: 2.809

2.  Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model.

Authors:  Sara Zalba; María J Garrido; María Merino; Teresa Lozano; Noelia Casares; Hugo Lana; Iñaki F Troconiz; Timo L M Ten Hagen; Grazyna Kochan; Pedro Berraondo
Journal:  J Nanobiotechnology       Date:  2021-04-13       Impact factor: 10.435

Review 3.  SARS-CoV-2 and COVID-19: A Narrative Review.

Authors:  A D Blann; R Heitmar
Journal:  Br J Biomed Sci       Date:  2022-09-06       Impact factor: 2.432

Review 4.  Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders.

Authors:  Piero Ruscitti; Alessandro Conforti; Marco Tasso; Luisa Costa; Francesco Caso; Paola Cipriani; Roberto Giacomelli
Journal:  Adv Rheumatol       Date:  2021-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.